March 11, 2020 07:00 AM EDTUpdated 01:50 PM

After hitting big in multiple myeloma, J&J, Genmab now have a new 'breakthrough' in NSCLC to boast about

Lending credence to J&J and Genmab’s promise that their alliance can produce something big outside of multiple myeloma, the FDA

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Af­ter hit­ting big in mul­ti­ple myelo­ma, J&J, Gen­mab now have a new 'break­through' in NSCLC to boast about